APA (7th ed.) Citation

Purushothaman Indu, Marimuthu Ragavan Rameshkumar, Narasingam Arunagirinathan, Naif Abdullah Al-Dhabi, Mariadhas Valan Arasu, & Savarimuthu Ignacimuthu. (2020). Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach. Elsevier.

Chicago Style (17th ed.) Citation

Purushothaman Indu, Marimuthu Ragavan Rameshkumar, Narasingam Arunagirinathan, Naif Abdullah Al-Dhabi, Mariadhas Valan Arasu, and Savarimuthu Ignacimuthu. Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine Against Main Protease and RNA-dependent RNA Polymerase of SARS-CoV-2: A Molecular Docking and Drug Repurposing Approach. Elsevier, 2020.

MLA (9th ed.) Citation

Purushothaman Indu, et al. Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine Against Main Protease and RNA-dependent RNA Polymerase of SARS-CoV-2: A Molecular Docking and Drug Repurposing Approach. Elsevier, 2020.